Adagene company information, Employees & Contact Information

Adagene announces up to $25 million strategic investment from Sanofi GlobeNewswire

Adagene’s ADG126 to be Highlighted in Two Presentations at the 2025 Chinese Society of Clinical Oncology (CSCO) Meeting in Jinan, China Yahoo Finance

Adagene Receives $25 Million Investment from Sanofi to Advance muzastotug and Launch New SAFEbody Discovery Program Nasdaq

Adagene Inc. Amends Collaboration Agreement with Exelixis to Advance SAFEbody Technology for Cancer Therapy Quiver Quantitative

Breakthrough Cancer Drug Technology: Adagene's 'Invisible' ADC Platform Expands to Third Program Stock Titan

Adagene Reports Six Months 2025 Financial Results and Provides Corporate Updates GlobeNewswire

Adagene to Present at Jefferies Global Healthcare Conference 2025 Macau Business

Adagene Appoints Immuno-Oncology Pioneer, Axel Hoos, M.D., Ph.D., as Executive Advisor Yahoo Finance

Biotech Innovator Adagene Scheduled for Major Wall Street Healthcare Conferences in September 2025 Stock Titan

Adagene Inc. to Participate in Jefferies Global Healthcare Conference 2025 with Fireside Chat and Investor Meetings Quiver Quantitative

Adagene Expands SAFEbody® Collaboration and License Agreement with Exelixis to Develop Third Novel Masked Antibody-Drug Conjugate GlobeNewswire

Adagene Enters $30B ADC Market Through Strategic ConjugateBio Partnership for Novel Cancer Therapeutics Stock Titan

Sanofi Bets $25M on Adagene: Strategic Investment, Clinical Trial Deal, and New Cancer Drug Program Stock Titan

Cancer Drug Breakthrough: Adagene's ADG126 Doubles Standard Survival Rate as Sanofi Backs Development Stock Titan

Adagene and ConjugateBio Partner to Develop Novel Antibody Drug Conjugate GlobeNewswire

Adagene's Cancer Drug Shows Breakthrough 29% Response Rate, FDA Fast-Tracks Phase 2 Trial Stock Titan

Adagene Reports Full Year 2024 Financial Results and Provides Corporate Update GlobeNewswire

Sanofi takes up option on Adagene bispecific and invests $25M, shielding partner from runway risk Fierce Biotech

Sanofi agrees to invest $25m in Adagene Pharmaceutical Technology

Sanofi takes option on third Adagene masked antibody, invests $25M FirstWord Pharma

Is Adagene (ADAG) Outperforming Other Medical Stocks This Year? Yahoo Finance

Phase 1b/2 study of ADG106, a 4-1BB/CD137 agonist, in combination with toripalimab in patients with advanced solid tumors ScienceDirect.com

Adagene expands clinical partnership with Merck for colorectal cancer treatment Clinical Trials Arena

H.C. Wainwright lowers Adagene stock price target to $7 on development path clarity Investing.com

Former YERVOY developer Axel Hoos joins Adagene as advisor Investing.com

Adagene Announces Clinical Data at SITC 2022 on Anti-CTLA-4 GlobeNewswire

Targeting CD137 (4-1BB) towards improved safety and efficacy for cancer immunotherapy Frontiers

Adagene stock gains as Sanofi expands agreement (ADAG:NASDAQ) Seeking Alpha

ADC Therapeutics calls it quits on solid tumor collaboration with Adagene Fierce Biotech

Adagene Announces Upto $25 Mln Investment From Sanofi, Stock Up In Pre-Market Nasdaq

Adagene (ADAG) Coverage Initiated by Leerink Partners with $7 PT GuruFocus

Fierce Pharma Asia—Vyvanse generics; Lenvima's trial flop; Adagene's ADC breakup Fierce Pharma

Sanofi picks a 'safe' bet for Adagene's antibody tech in $2.5B biobucks tie up Fierce Biotech

Adagene Receives FDA Guidance On Future Clinical Development Of Experimental Cancer Drug: Retail Turns Optimistic Stocktwits

Adagene Marie Teske Obituary (2025) - Hermantown, MN - Sunrise Funeral Home, Cremation Services & Cemetery Legacy obituary

Adagene Completes $69 Million Series D Financing Led by Growth Investor General Atlantic General Atlantic

Adagene stock jumps after Sanofi’s $25 million strategic investment By Investing.com Investing.com Nigeria

ADAG IPO News - Chinese cancer biotech Adagene files for a $125 million US IPO renaissancecapital.com

Adagene Presents Interim Results Reinforcing Best-in-Class Profile of Masked anti-CTLA-4 SAFEbody® ADG126 ANTARA News

Adagene plans $125M IPO to go after cancer niches targeted by BMS and Pfizer Fierce Biotech

ADAG - Adagene Inc. Latest Stock News & Market Updates Stock Titan

China’s Adagene raises $50M to take anticancer antibodies into the clinic Fierce Biotech